Additionally, studies have shown that the FTO inhibitor FB23-2, when combined with radiotherapy, significantly inhibits tumor spheroid formation and the self-renewal capacity of GSCs, suppresses cell proliferation, and induces apoptosis in GBM cells. Here, FTO is linked to neoplasm.